德国拜耳利伐沙班的适应症

Rivaroxaban is the world's first oral direct factor Xa inhibitor, mainly used to treat venous thrombosis in adults. Compared with traditional anticoagulants, Rivaroxaban has accurate efficacy, does not require constant monitoring, has good safety and is easy to use. It is expected to become an alternative drug to heparin and vitamin K antagonists.

Indications of Germany's Bayer Rivaroxaban: Rivaroxaban is used in adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis (VTE); used to treat venous thrombosis (DVT) in adults to reduce the recurrence and recurrence of DVT after acute DVT. Risk of pulmonary embolism (PE); for use in adult patients with non-valvular atrial fibrillation who have one or more risk factors (e.g., congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, history of stroke or transient ischemic attack) to reduce the risk of stroke and systemic embolism.

Bayer is headquartered in Leverkusen, Germany. Polymers, pharmaceuticals and health care, chemicals and agriculture are the company's four pillar industries. The company's product categories exceed 10,000 types. The company has produced aspirin, heroin, Rivaroxaban and other products.

It is understood that the current specifications of Rivaroxaban, which is more cost-effective, are: 20mg*28 tablets and 15mg*28 tablets, which are sold for about $350. Affected by factors such as exchange rate fluctuations, prices are not fixed. If patients want to know the specific price information of rivaroxaban, they can consult the medical companion travel service.

Almost every drug will have certain side effects or adverse reactions after taking it. After treatment with Rivaroxaban, patients can decide whether to continue taking the drug based on their own situation if they have mild side effects. If they have serious side effects, they should inform their doctor as soon as possible.

The above is the introduction about Rivaroxaban. If patients have other questions about Rivaroxaban, they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/89993.html